Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

The electronic health records market is experiencing robust growth, primarily driven by the increasing incidence of chronic diseases that require ong ...

Rising neurological issues, tech advances in wearables, and more healthcare investment are driving growth in the brain monitoring market. INDORE, INDIA, June 17, 2025 /EINPresswire.com/ -- Brain ...

The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...

Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

The study population was drawn from a 5% random sample of Medicare beneficiaries with diabetes enrolled in Medicare Part D in 2007 and 2008. Patients had cancer newly diagnosed between January and ...

Burmachuk says numerous family members gathered at HSC, and the doctor there told them their grandmother’s medical reaction was due to a combination of her diabetes medication, metformin, and ...

Learn about type 1, type 2, and gestational diabetes symptoms, causes, diagnosis, treatment, diet, management, and diabetes prevention.

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effective diabetes management tools. Growing awareness ...

Nasdaq Forecast Today 05/06: Gains Again (Chart) Date. 2025-06-05 02:15:57. ... Ready to trade our stock market forecast and analysis? Here are the best CFD stocks brokers to choose from.